InMed Pharmaceuticals Inc. (MTRI) stock

MTRINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as INM

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/30

$18.35+2.74 (+17.56%)

Close on Nov 12, 2026Market cap $100.81MP/E –Yield –

InMed Pharmaceuticals statistics

48 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $100.81M; $280.48M
Enterprise Value: $99.71M; $148.62M

Share statisticsIndustry

Shares Outstanding: 5M; 58M
Shares Change (YoY): 150.7%; 10.9%
Shares Change (QoQ): 2.89%; 0.51%
Float: 4M; 49M
Shares Held by Insiders: 25.5%; 12.1%
Shares Held by Institutions: 49.1%; 56.4%

Stock price statisticsIndustry

52-Week High: $23.30; –
52-Week Low: $5.70; –
20-Day Moving Average: $15.15; –
50-Day Moving Average: $14.12; –
200-Day Moving Average: $12.24; –
Average True Range (14): $2.20; –
Price Change (1 Week): 38.9%; 1.51%
Price Change (1 Month): 40.1%; -2.35%
Price Change (3 Months): 24.8%; -21.1%
Price Change (6 Months): 182.3%; -22.6%
Price Change (YTD): 73.1%; -22.6%
Price Change (1 Year): 5.46%; -20.7%
Price Change (3 Years): -76.2%; -27.4%
Price Change (5 Years): -99.7%; -77.3%
Average Volume (10 Days): 42,479; –
Average Volume (20 Days): 24,901; –
Average Volume (90 Days): 70,781; –
Relative Volume: 2.10; 0.79
Relative Strength Index (14): 60.4; 44.7
Volatility (1 Year): 161.3%; 80.4%
Beta (5 Years): 2.21; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -253.4%; -51.2%
Return on Assets (ROA): -179.5%; -40.6%

EfficiencyIndustry

Profits Per Employee: -$2.19M; -$683.67K
Employee Count: 6; 75
WACC: 16.0%; 10.1%

Income statement (TTM)Industry

Pretax Income: -$11.66M; -$13.23M
Net Income: -$13.16M; -$21.61M
EBITDA: -$11.50M; -$16.85M
EPS (Diluted): -$2.90; -$0.75

Balance sheetIndustry

Cash & Short-Term Investments: $1.10M; $67.63M
Net Cash (Debt): $1.10M; $17.46M
Net Cash Per Share: $0.20; $0.72
Equity (Book Value): -$1.20M; $53.27M
Book Value Per Share: -$0.22; $1.50
Tangible Book Value: -$1.20M; $26.82M

Cash flow (TTM)Industry

Operating Cash Flow: -$7.86M; -$12.27M

Dividends and yieldsIndustry

Earnings Yield: -13.1%; -20.8%

Scores and fair valueIndustry

Altman Z-Score: -117.97; 0.30
Piotroski F-Score: 1; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	MTRI	S&P 500	Difference	MTRI per year	S&P 500 per year
1 month	+34.9%	-2.7%	+37.6 pts
3 months	+27.4%	-1.7%	+29.2 pts
Year to date	+73.1%	+11.9%	+61.2 pts
1 year	+6.1%	+12.0%	−5.9 pts
3 years	-76.4%	+78.2%	−154.6 pts	-38.2%	+21.2%
5 years	-99.7%	+73.2%	−173.0 pts	-69.5%	+11.6%

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?